162 related articles for article (PubMed ID: 29760569)
41. Coprescribing of Benzodiazepines and Opioids in Older Adults: Rates, Correlates, and National Trends.
Rhee TG
J Gerontol A Biol Sci Med Sci; 2019 Nov; 74(12):1910-1915. PubMed ID: 30561526
[TBL] [Abstract][Full Text] [Related]
42. Association between first-line antidepressant use and risk of dementia in older adults: a retrospective cohort study.
Wang HG; Chen WH; Chang SH; Zhang T; Shao H; Guo J; Lo-Ciganic WH
Res Sq; 2023 Sep; ():. PubMed ID: 37790299
[TBL] [Abstract][Full Text] [Related]
43. Education and decision making at the time of triptan prescribing: patient expectations vs actual practice.
Mathew PG; Pavlovic JM; Lettich A; Wells RE; Robertson CE; Mullin K; Charleston Iv L; Dodick DW; Schwedt TJ
Headache; 2014 Apr; 54(4):698-708. PubMed ID: 24512184
[TBL] [Abstract][Full Text] [Related]
44. Rates and reasons for discontinuation of triptans and opioids in episodic migraine: results from the American Migraine Prevalence and Prevention (AMPP) study.
Holland S; Fanning KM; Serrano D; Buse DC; Reed ML; Lipton RB
J Neurol Sci; 2013 Mar; 326(1-2):10-7. PubMed ID: 23394974
[TBL] [Abstract][Full Text] [Related]
45. Trends in the prescribing of antidepressant pharmacotherapy: office-based visits, 1990-1995.
Sclar DA; Robinson LM; Skaer TL; Galin RS
Clin Ther; 1998; 20(4):871-84; 870. PubMed ID: 9737843
[TBL] [Abstract][Full Text] [Related]
46. Trends in Prescribing of Selective Serotonin Reuptake Inhibitors and Other Newer Antidepressant Agents in Adult Primary Care.
Pirraglia PA; Stafford RS; Singer DE
Prim Care Companion J Clin Psychiatry; 2003 Aug; 5(4):153-157. PubMed ID: 15213776
[TBL] [Abstract][Full Text] [Related]
47. Rates of 5 common antidepressant side effects among new adult and adolescent cases of depression: a retrospective US claims study.
Anderson HD; Pace WD; Libby AM; West DR; Valuck RJ
Clin Ther; 2012 Jan; 34(1):113-23. PubMed ID: 22177545
[TBL] [Abstract][Full Text] [Related]
48. Trends in Opioid Use in Pediatric Patients in US Emergency Departments From 2006 to 2015.
Tomaszewski DM; Arbuckle C; Yang S; Linstead E
JAMA Netw Open; 2018 Dec; 1(8):e186161. PubMed ID: 30646317
[TBL] [Abstract][Full Text] [Related]
49. Combining opioid and adrenergic mechanisms for chronic pain.
Smith HS; Raffa RB; Pergolizzi JV; Taylor R; Tallarida RJ
Postgrad Med; 2014 Jul; 126(4):98-114. PubMed ID: 25141248
[TBL] [Abstract][Full Text] [Related]
50. Comparison of Opioids Prescribed for Patients at Risk for Opioid Misuse Before and After Publication of the Centers for Disease Control and Prevention's Opioid Prescribing Guidelines.
Scherrer JF; Tucker J; Salas J; Zhang Z; Grucza R
JAMA Netw Open; 2020 Dec; 3(12):e2027481. PubMed ID: 33263762
[TBL] [Abstract][Full Text] [Related]
51. Utilization patterns, cardiovascular risk, and concomitant serotoninergic medications among triptan users between 2008 and 2018: A gender analysis in one Italian region, Tuscany.
Hyeraci G; Gini R; Bezin J; Iannone LF; Benemei S; Lupi C; De Cesaris F; Geppetti P; Roberto G
Headache; 2023 Feb; 63(2):222-232. PubMed ID: 36705316
[TBL] [Abstract][Full Text] [Related]
52. Physician and patient factors associated with the prescribing of medications for sleep difficulties that are associated with high abuse potential or are expensive: an analysis of data from the National Ambulatory Medical Care Survey for 1996-2001.
Rasu RS; Shenolikar RA; Nahata MC; Balkrishnan R
Clin Ther; 2005 Dec; 27(12):1970-9. PubMed ID: 16507384
[TBL] [Abstract][Full Text] [Related]
53. Opioid Medications Prescribing and the Pain-Depression Dyad in Primary Care: Analysis of 2014-2015 National Ambulatory Medical Care Survey (NAMCS) Data.
Lin SX; Patel K; Younge RG
J Am Board Fam Med; 2019; 32(4):614-618. PubMed ID: 31300583
[TBL] [Abstract][Full Text] [Related]
54. Trends in opioid prescribing and co-prescribing of sedative hypnotics for acute and chronic musculoskeletal pain: 2001-2010.
Larochelle MR; Zhang F; Ross-Degnan D; Wharam JF
Pharmacoepidemiol Drug Saf; 2015 Aug; 24(8):885-92. PubMed ID: 25906971
[TBL] [Abstract][Full Text] [Related]
55. Concomitant Use of Atypical Antipsychotics With Other Psychotropic Medication Classes and the Risk of Type 2 Diabetes Mellitus.
Burcu M; Zito JM; Safer DJ; Magder LS; dosReis S; Shaya FT; Rosenthal GL
J Am Acad Child Adolesc Psychiatry; 2017 Aug; 56(8):642-651. PubMed ID: 28735693
[TBL] [Abstract][Full Text] [Related]
56. Increased Readmission Rates in Younger Male Patients Due to Suicidal Risk in Newly Diagnosed Depressive Disorders After Initiation of Serotonin Reuptake Inhibitors.
Pagan Colon IE; Kroin J; Kaushal S; Khan S; Alvarez Villalba CL
Cureus; 2022 Nov; 14(11):e31987. PubMed ID: 36589188
[TBL] [Abstract][Full Text] [Related]
57. Comparison of Opioid Prescribing by Dentists in the United States and England.
Suda KJ; Durkin MJ; Calip GS; Gellad WF; Kim H; Lockhart PB; Rowan SA; Thornhill MH
JAMA Netw Open; 2019 May; 2(5):e194303. PubMed ID: 31125102
[TBL] [Abstract][Full Text] [Related]
58. Access to a tailored mobile application enhances medication adherence among young users of antidepressants.
Larsen RE; Hole K; Selle ML; Johannessen Landmark C; Krogstad T; Holm LB
Front Pharmacol; 2024; 15():1379700. PubMed ID: 38659579
[TBL] [Abstract][Full Text] [Related]
59. Trends in medication prescribing for pediatric sleep difficulties in US outpatient settings.
Stojanovski SD; Rasu RS; Balkrishnan R; Nahata MC
Sleep; 2007 Aug; 30(8):1013-7. PubMed ID: 17702271
[TBL] [Abstract][Full Text] [Related]
60. The effect of selective serotonin and norepinephrine reuptake inhibitors on clinical outcome of COVID-19 patients: A systematic review and meta-analysis.
Firouzabadi D; Kheshti F; Abdollahifard S; Taherifard E; Kheshti MR
Health Sci Rep; 2022 Nov; 5(6):e892. PubMed ID: 36268458
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
